Albarico, Roselle E.
HRN: 02-63-69 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2026
CEFUROXIME 1.5GM (VIAL)
01/20/2026
01/21/2026
IV
1.5gms
Q8hrs X 3 Doses
S/P Primary LSTCS With Intra CS IUD Insertion
Checking Initial Appropriateness
01/21/2026
CEFUROXIME 500MG (TAB)
01/21/2026
01/28/2026
ORAL
500mg
BID
S/P CS
Checking Initial Appropriateness